-
The search continues for a missing child after a gravel slide in Minnesota.More >> The state has more than 600 life jacket loaners.More >> A home in the town of Washington explodes while the family is away on vacation.More >> St. Paul Fire Chief Steve Zaccard talks about the death of one child and rescue efforts at a land slide in a St. Paul park Wednesday afternoon.More >> St. Paul Fire Chief Steve Zaccard talks about the death of one child and rescue efforts at a land slide in a St. Paul park Wednesday afternoon.More >> Opponents of new national education standards are hoping to put a stop to them.More >>
WASHINGTON (WKOW) -- The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection
The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.
Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are infected with the virus.
But company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 percent, when accompanied by condoms and counseling.
Click here to read the FDA's full release on this announcement.
